Samuel P. Sears Jr.

Director, Inhibitor Therapeutics, Inc.

Companies

Inhibitor Therapeutics, Inc.Board member Jan 11, 2006 to now¹
BIODELIVERY SCIENCES INTERNATIONAL INCBoard member Oct 27, 2011 to Nov 17, 2017²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Inhibitor Therapeutics, Inc. INTI1,229,543 shares³$135.2K at $0.11May 4, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

May 4, 2026Granted 50,000 shares of Inhibitor Therapeutics, Inc.³
Apr 1, 2025Granted 50,000 shares of Inhibitor Therapeutics, Inc.⁴
Apr 1, 2024Granted 50,000 shares of Inhibitor Therapeutics, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARInhibitor Therapeutics, Inc., Board member
2
SEC EDGARBIODELIVERY SCIENCES INTERNATIONAL INC, Board member
3
SEC EDGARInhibitor Therapeutics, Inc. shares after the filing of May 4, 2026
4
SEC EDGARForm 4 filed Apr 7, 2025
5
SEC EDGARForm 4 filed May 16, 2024